ANCA

You have accessRestricted Access
Identifying Antigen-Specific T Cells in ANCA-Associated Vasculitis: A Glimpse of the Future?
Lani Shochet and A. Richard Kitching

JASN August 2022, 33 (8) 1435-1437; DOI: https://doi.org/10.1681/ASN.2022060668

Add to Selected Citations
You have accessRestricted Access
Immunological Interaction of HLA-DPB1 and Proteinase 3 in ANCA Vasculitis is Associated with Clinical Disease Activity
Dhruti P. Chen, Elizabeth A. McInnis, Eveline Y. Wu, Katherine G. Stember, Susan L. Hogan, Yichun Hu, Candace D. Henderson, Lauren N. Blazek, Simon Mallal, Edita Karosiene, Bjoern Peters, John Sidney, Eddie A. James, William W. Kwok, J. Charles Jennette, Dominic J. Ciavatta, Ronald J. Falk and Meghan E. Free

JASN August 2022, 33 (8) 1517-1527; DOI: https://doi.org/10.1681/ASN.2021081142

Add to Selected Citations
You have accessRestricted Access
Kidney Histopathology in ANCA-Associated Vasculitides Treated with Plasma Exchange
Marta Casal Moura, Maria José Soler, Sanjeev Sethi, Fernando C. Fervenza and Ulrich Specks

JASN June 2022, 33 (6) 1223-1224; DOI: https://doi.org/10.1681/ASN.2022020164

Add to Selected Citations
You have accessRestricted Access
Authors’ Reply: Kidney Histopathology in ANCA-Associated Vasculitides Treated with Plasma Exchange
Dorian Nezam, Raphaël Porcher, François Grolleau and Benjamin Terrier; on behalf of the French Vasculitis Study Group

JASN June 2022, 33 (6) 1224-1225; DOI: https://doi.org/10.1681/ASN.2022030269

Add to Selected Citations
You have accessRestricted Access
Unveiling the Role of Additional Histological Parameters in ANCA-Associated Vasculitis
Vincenzo L’Imperio and Fabio Pagni

JASN June 2022, 33 (6) 1226-1227; DOI: https://doi.org/10.1681/ASN.2022020208

Add to Selected Citations
You have accessRestricted Access
A View on Cathepsin C as a Target for Therapy in AAV
Renate Kain and Maja C. Nackenhorst

JASN May 2022, 33 (5) 875-878; DOI: https://doi.org/10.1681/ASN.2022030309

Add to Selected Citations
You have accessRestricted Access
Targeting Cathepsin C in PR3-ANCA Vasculitis
Uwe Jerke, Claudia Eulenberg-Gustavus, Anthony Rousselle, Paul Nicklin, Stefan Kreideweiss, Marc A. Grundl, Peter Eickholz, Katrin Nickles, Adrian Schreiber, Brice Korkmaz and Ralph Kettritz

JASN May 2022, 33 (5) 936-947; DOI: https://doi.org/10.1681/ASN.2021081112

Add to Selected Citations
You have accessRestricted Access
Arteritis Status and Renal Involvement in ANCA-Associated Vasculitis
Joop P. Aendekerk, Sjoerd A.M.E.G. Timmermans, Matthias H. Busch, Pieter van Paassen and the Limburg Renal Registry

JASN February 2022, 33 (2) 457-458; DOI: https://doi.org/10.1681/ASN.2021091236

Add to Selected Citations
You have accessRestricted Access
Authors’ Reply
Idris Boudhabhay, Guillaume Coutance, Alexandre Karras and Jean Paul Duong Van Huyen

JASN February 2022, 33 (2) 458-459; DOI: https://doi.org/10.1681/ASN.2021111413

Add to Selected Citations
You have accessRestricted Access
The Clinical Application of Urine Soluble CD163 in ANCA-Associated Vasculitis
Sarah M. Moran, Jennifer Scott, Michael R. Clarkson, Niall Conlon, Jean Dunne, Matthew D. Griffin, Tomas P. Griffin, Elizabeth Groarke, John Holian, Conor Judge, Jason Wyse, Kirsty McLoughlin, Paul V. O’Hara, Matthias Kretzler, Mark A. Little and Nephrotic Syndrome Study Network (NEPTUNE)

JASN November 2021, 32 (11) 2920-2932; DOI: https://doi.org/10.1681/ASN.2021030382

Add to Selected Citations

Main menu

User menu

Search

ANCA

Pages

Articles

Information for Authors

About

Journal Information

More Information